Population pharmacokinetic modeling of intramuscular and oral dexamethasone and betamethasone in Indian women

[1]  J. Cidlowski,et al.  After 62 years of regulating immunity, dexamethasone meets COVID-19 , 2020, Nature Reviews Immunology.

[2]  D. DuBois,et al.  Physiologically Based Pharmacokinetics of Dexamethasone in Rats , 2020, Drug Metabolism and Disposition.

[3]  D. Weiner,et al.  Serum Concentrations, Pharmacokinetic/Pharmacodynamic Modeling and Effects of Dexamethasone on Inflammatory Mediators following Intravenous and Oral Administration to Exercised Horses. , 2020, Drug testing and analysis.

[4]  M. Gissler,et al.  Associations Between Maternal Antenatal Corticosteroid Treatment and Mental and Behavioral Disorders in Children. , 2020, JAMA.

[5]  Y. Ville,et al.  Maternal Betamethasone for Prevention of Respiratory Distress Syndrome in Neonates: Population Pharmacokinetic and Pharmacodynamic Approach , 2020, Clinical pharmacology and therapeutics.

[6]  W. Jusko,et al.  Pharmacokinetics and Pharmacodynamics of Intramuscular and Oral Betamethasone and Dexamethasone in Reproductive Age Women in India , 2019, Clinical and translational science.

[7]  M. Milad,et al.  Evaluation of Maternal Drug Exposure Following the Administration of Antenatal Corticosteroids During Late Pregnancy Using Physiologically‐Based Pharmacokinetic Modeling , 2019, Clinical pharmacology and therapeutics.

[8]  J. Dressman,et al.  Solubility Determination of Active Pharmaceutical Ingredients Which Have Been Recently Added to the List of Essential Medicines in the Context of the Biopharmaceutics Classification System-Biowaiver. , 2018, Journal of pharmaceutical sciences.

[9]  A. Rowland,et al.  Assessment of inter-racial variability in CYP3A4 activity and inducibility among healthy adult males of Caucasian and South Asian ancestries , 2018, European Journal of Clinical Pharmacology.

[10]  Julie Brown,et al.  Antenatal Corticosteroids for Accelerating Fetal Lung Maturation for Women at Risk of Preterm Birth , 2007, The Cochrane database of systematic reviews.

[11]  Hyunyoung Jeong,et al.  Betamethasone in pregnancy: influence of maternal body weight and multiple gestation on pharmacokinetics. , 2010, American journal of obstetrics and gynecology.

[12]  W. Jusko,et al.  Population Pharmacokinetic/Pharmacodynamic Modeling of Systemic Corticosteroid Inhibition of Whole Blood Lymphocytes: Modeling Interoccasion Pharmacodynamic Variability , 2007, Pharmaceutical Research.

[13]  W. Jusko,et al.  BETAMETHASONE PHARMACOKINETICS AFTER TWO PRODRUG FORMULATIONS IN SHEEP: IMPLICATIONS FOR ANTENATAL CORTICOSTEROID USE , 2005, Drug Metabolism and Disposition.

[14]  D. Farine,et al.  Antenatal corticosteroid therapy for fetal maturation , 1995, Pediatric Clinical Practice Guidelines & Policies.

[15]  Stuart L. Beal,et al.  Ways to Fit a PK Model with Some Data Below the Quantification Limit , 2001, Journal of Pharmacokinetics and Pharmacodynamics.

[16]  W. Oelkers,et al.  Metabolism of dexamethasone in the human kidney: nicotinamide adenine dinucleotide-dependent 11beta-reduction. , 1997, The Journal of clinical endocrinology and metabolism.

[17]  B. K. Park,et al.  Dexamethasone metabolism by human liver in vitro. Metabolite identification and inhibition of 6-hydroxylation. , 1996, The Journal of pharmacology and experimental therapeutics.

[18]  G. Read,et al.  The pharmacokinetics of oral and intramuscular administration of dexamethasone in late pregnancy , 1996, Acta obstetricia et gynecologica Scandinavica.

[19]  H. Möllmann,et al.  Pharmacokinetics of dexamethasone and its phosphate ester. , 1987, Biopharmaceutics & drug disposition.

[20]  R. Nation,et al.  Disposition of betamethasone in parturient women after intramuscular administration. , 1984, British journal of clinical pharmacology.

[21]  W. Jusko,et al.  Effect of smoking on prednisone, prednisolone, and dexamethasone pharmacokinetics , 1981, Journal of Pharmacokinetics and Biopharmaceutics.

[22]  R. Moore,et al.  Disposition of synthetic glucocorticoids I. Pharmacokinetics of dexamethasone in healthy adults , 1979, Journal of Pharmacokinetics and Biopharmaceutics.

[23]  J. Wagner.  Linear pharmacokinetic models and vanishing exponential terms: Implications in pharmacokinetics , 1976, Journal of Pharmacokinetics and Biopharmaceutics.

[24]  N. Najib,et al.  Pharmacokinetics of betamethasone after single-dose intramuscular administration of betamethasone phosphate and betamethasone acetate to healthy subjects. , 2012, Clinical therapeutics.

[25]  E. Graul,et al.  Dose-dependent pharmacokinetics of dexamethasone , 2004, European Journal of Clinical Pharmacology.

[26]  R. Moore,et al.  Pharmacokinetics of betamethasone in healthy adults after intravenous administration , 2004, European Journal of Clinical Pharmacology.